Adaptive design methods in clinical trials – a review
Shein-Chung Chow,Mark Chang +1 more
Reads0
Chats0
TLDR
Several commonly considered adaptive designs in clinical trials are reviewed and some examples concerning the development of Velcade intended for multiple myeloma and non-Hodgkin's lymphoma are given.Abstract:
In recent years, the use of adaptive design methods in clinical research and development based on accrued data has become very popular due to its flexibility and efficiency. Based on adaptations applied, adaptive designs can be classified into three categories: prospective, concurrent (ad hoc), and retrospective adaptive designs. An adaptive design allows modifications made to trial and/or statistical procedures of ongoing clinical trials. However, it is a concern that the actual patient population after the adaptations could deviate from the originally target patient population and consequently the overall type I error (to erroneously claim efficacy for an infective drug) rate may not be controlled. In addition, major adaptations of trial and/or statistical procedures of on-going trials may result in a totally different trial that is unable to address the scientific/medical questions the trial intends to answer. In this article, several commonly considered adaptive designs in clinical trials are reviewed. Impacts of ad hoc adaptations (protocol amendments), challenges in by design (prospective) adaptations, and obstacles of retrospective adaptations are described. Strategies for the use of adaptive design in clinical development of rare diseases are discussed. Some examples concerning the development of Velcade intended for multiple myeloma and non-Hodgkin's lymphoma are given. Practical issues that are commonly encountered when implementing adaptive design methods in clinical trials are also discussed.read more
Citations
More filters
Journal ArticleDOI
A tutorial on pilot studies: the what, why and how
Lehana Thabane,Lehana Thabane,Jinhui Ma,Jinhui Ma,Rong Chu,Rong Chu,Ji Cheng,Ji Cheng,Afisi S. Ismaila,Afisi S. Ismaila,Lorena P. Rios,Lorena P. Rios,Reid Robson,Marroon Thabane,Lora Giangregorio,Charles H. Goldsmith,Charles H. Goldsmith +16 more
TL;DR: A detailed examination of the key aspects of pilot studies for phase III trials including the general reasons for conducting a pilot study, the relationships between pilot studies, proof-of-concept studies, and adaptive designs, and some suggestions on how to report the results of pilot investigations using the CONSORT format.
Book
Best Care at Lower Cost: The Path to Continuously Learning Health Care in America
TL;DR: The knowledge and tools exist to put the health system on the right course to achieve continuous improvement and better quality care at a lower cost, and a better use of data is a critical element of a continuously improving health system.
Journal ArticleDOI
A "SMART" Design for Building Individualized Treatment Sequences
TL;DR: The Sequential Multiple Assignment Randomized Trial (SMART) is reviewed and its advantages in constructing and revising adaptive interventions as compared to alternative experimental designs are highlighted.
Journal ArticleDOI
Adaptive designs in clinical trials: why use them, and how to run and report them
Philip Pallmann,Alun Bedding,Babak Choodari-Oskooei,Munyaradzi Dimairo,Laura Flight,Lisa V. Hampson,Lisa V. Hampson,Jane Holmes,Adrian Mander,Lang’o Odondi,Matthew R. Sydes,Sofia S. Villar,James Wason,James Wason,Christopher J. Weir,Graham M. Wheeler,Graham M. Wheeler,Christina Yap,Thomas Jaki +18 more
TL;DR: This tutorial paper provides guidance on key aspects of adaptive designs that are relevant to clinical triallists, and emphasises the general principles of transparency and reproducibility and suggest how best to put them into practice.
Journal ArticleDOI
67A Designed extension of studies based on conditional power
TL;DR: A flexible method of extending a study based on conditional power, where the significance of the treatment difference at the planned end is used to determine the number of additional observations needed and the critical value necessary after accruing those additional observations.
References
More filters
Journal ArticleDOI
Continual reassessment method: a practical design for phase 1 clinical trials in cancer.
TL;DR: A new approach to the design and analysis of Phase 1 clinical trials in cancer and a particularly simple model is looked at that enables the use of models whose only requirements are that locally they reasonably well approximate the true probability of toxic response.
Book
Group Sequential Methods with Applications to Clinical Trials
TL;DR: A short history of sequential and group sequential methods can be found in this paper, where the authors present a road map for the application of two-sided tests for comparing two treatments with normal response of known variance.
Journal ArticleDOI
Forcing a sequential experiment to be balanced
TL;DR: In this paper, a new method of assigning the subjects which tends to balance the experiment, but at the same time is not over vulnerable to various common forms of experimental bias is discussed.
Journal ArticleDOI
Adaptive sample size calculations in group sequential trials.
Walter Lehmacher,Gernot Wassmer +1 more
TL;DR: A method for group sequential trials that is based on the inverse normal method for combining the results of the separate stages is proposed, which enables data-driven sample size reassessments during the course of the study.
Journal ArticleDOI
Modification of Sample Size in Group Sequential Clinical Trials
Lu Cui,H. M. J. Hung,S.-J. Wang +2 more
TL;DR: A new group sequential test procedure is developed by modifying the weights used in the traditional repeated significance two-sample mean test, which has the type I error probability preserved at the target level and can provide a substantial gain in power with the increase of sample size.